An Open-label, Single-arm, Phase 2 Trial of Panitumumab Plus FOLFIRI as Second-line Therapy in Patients with Metastatic Colorectal Cancer

201140 citationsJournal Article

Authors

Good health and well-being

Published in: Clinical Colorectal Cancer

Volume 10, Issue 3, pp. 171-177

Field-Weighted Citation Impact: 2.25